Target intelligence / Profile preview

Heterochromatin protein 1 (HP1) (HP1)

Target
HP1
Molecular classification
Histone reader, Chromodomain-containing protein, Transcription corepressor, Non-histone chromosomal protein
01

Overview

Heterochromatin protein 1 (HP1) is a family of highly conserved non-histone chromosomal proteins essential for the structural organization of the nucleus and the regulation of gene expression. In humans, the family includes three isoforms—HP1α (CBX5), HP1β (CBX1), and HP1γ (CBX3)—which function as epigenetic "readers" by binding to trimethylated lysine 9 of histone H3 (H3K9me3) through their N-terminal chromodomain. This interaction promotes the formation of repressive heterochromatin, leading to transcriptional silencing of specific genomic regions. Beyond gene repression, HP1 proteins are involved in critical cellular processes including DNA damage repair, chromosome segregation during mitosis, and the maintenance of telomere integrity. Dysregulation of HP1 expression is linked to various pathologies, particularly cancer, where it can influence tumor progression, metastasis, and resistance to therapy. As a result, HP1 is being investigated as a therapeutic target, with experimental small molecules designed to disrupt its binding to methylated histones to modulate the epigenetic landscape in disease states.

Other names
Chromobox protein homologCBXHP1 alphaHP1 betaHP1 gammaAntigen p25Heterochromatin protein 1 homolog alphaHeterochromatin protein 1 homolog betaHeterochromatin protein 1 homolog gamma
02

Mechanism of action

Inhibition of the interaction between the HP1 chromodomain and trimethylated histone H3 lysine 9 (H3K9me3)

03

Biological functions

Heterochromatin formationGene silencingDNA repairCell cycle regulationChromosome segregationTelomere maintenanceAlternative splicing
04

Disease associations

CancerViral infectionAgingCellular senescence
05

Safety considerations

Genomic instabilityOff-target epigenetic effectsIsoform-specific toxicityDisruption of normal gene silencing
06

Interacting drugs

UNC0638

2 more in the full profile.

07

Biomarkers

HP1 alpha expression levelHP1 gamma expression levelSenescence-associated heterochromatin foci (SAHF)

Beyond the preview

Go deeper on Heterochromatin protein 1 (HP1) (HP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterochromatin protein 1 (HP1) (HP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call